We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in ANACOR PHARMACEUTICALS INC COM in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $5.74M → $0 (-$5.74M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
KCM
Kingdon Capital Management
New York
-$5.41M
2
CIM
CIM Investment Management
Pennsylvania
-$335K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Kingdon Capital Management
New York
– -$5.41M -54,476 Closed
CIM
2
CIM Investment Management
Pennsylvania
– -$335K -3,377 Closed

ANAC Hedge Fund Activity: Q3 2016 in Review

0 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q3 2016, worth a combined $0 — down 100% from $5.74M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ANAC and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Kingdon Capital Management, exiting entirely with an estimated $5.41M sold.

  • 0 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q3 2016, down from 2 in Q2 2016.
  • Funds reported $0 of ANACOR PHARMACEUTICALS INC COM stock for Q3 2016, down 100% quarter-over-quarter.
  • 0 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q3 2016 and 2 closed out, a net change of -2 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q3 2016 was Kingdon Capital Management, an estimated $5.41M sold.

Based on aggregated 13F filings for Q3 2016.